Author:
Ben Mahmoud L.,Hakim A.,Ghozzi H.,Atheymen R.,Sahnoun Z.,Zeghal K.
Subject
Clinical Neurology,Neurology
Reference27 articles.
1. Pharmacokinetics, drug interactions, and tolerability of valproate;DeVane;Psychopharmacol Bull,2003
2. Effect of aging on glucuronidation of valproic acid in human liver microsomes and the role of UDP-glucuronosyl transferase UGT1A4, UGT1A8, and UGT1A10;Argikar;Drug Metab Dispos,2009
3. Effects of CYP2C19 and CYP2C9 genotypes on pharmacokinetic variability of valproic acid in Chinese epileptic patients: nonlinear mixed-effect modeling;Jiang;Eur J Clin Pharmacol,2009
4. Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs;Patsalos;Lancet Neurol,2003
5. The influence of cytochrome oxidase CYP2A6, CYP2B6, and CYP2C9 polymorphisms on the plasma concentrations of valproic acid in epileptic patients;Tan;Clin Neurol Neurosurg,2010
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献